US2005080238A1PendingUtilityA1

Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates

Priority: Oct 19, 2001Filed: Oct 4, 2004Published: Apr 14, 2005
Est. expiryOct 19, 2021(expired)· nominal 20-yr term from priority
C07K 16/065
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The method for immune serum globulin purification relates to the purification of immune globulins from blood plasma with a high degree of efficiency and a high rate of recovery. The immune globulin source is Cohn's fraction I+II+III or II+III prepared from plasma or plasma intermediates by precipitation of the paste at pH 5.7 to 5.8 in the presence of 20% ethanol and 80% purified water. A glycine extraction is followed by an anion exchange chromatography column step to achieve a significantly high yield and high purity of the concentrated protein.

Claims

exact text as granted — not AI-modified
1 - 37 . (canceled)  
     
     
         38 . A method for producing a high yield of purified immune globulins, comprising: 
 suspending immune globulins in an ethanol solution;    adjusting the pH of the suspension to about 5.7 to 5.8;    incubating the suspension for at least two hours;    adding a solution of glycine, ethanol and water to the suspension;    adjusting the pH of the suspension to about 5.2 to 5.4;    extracting the immune globulins from the suspension in a liquid phase to provide an extract containing immune globulins;    concentrating the extract containing immune globulins, and removing any impurities from the extract containing immune globulins using an anion exchange chromatography column to provide a purified extract solution containing immune globulins;    concentrating the purified extract solution containing immune globulins to provide a concentrated purified extract solution containing immune globulins;    treating the concentrated purified extract solution containing immune globulins with a solvent-detergent mixture to inactivate viruses, and removing the solvent-detergent mixture from the concentrated purified extract solution containing immune globulins; and    formulating the concentrated purified extract solution containing immune globulins for final use.    
     
     
         39 . The method of  claim 38 , wherein the ethanol solution is comprised of about 19% ethanol and about 81% purified water.  
     
     
         40 . The method of  claim 38 , wherein the step of suspending the immune globulins in the ethanol solution occurs at a temperature of about −5° C.  
     
     
         41 . The method of  claim 38 , wherein the step of adding the solution of glycine, ethanol and water to the suspension comprises producing a final concentration of glycine in the suspension of about 0.8M and a final concentration of ethanol in the suspension of about 15% (volume/volume).  
     
     
         42 . The method of  claim 38 , wherein the step of extracting the immune globulins from the suspension is performed by one of centrifugation and filtration.  
     
     
         43 . The method of  claim 38 , wherein the step of extracting the immune globulins from the suspension is performed by use of a filter press.  
     
     
         44 . The method of  claim 38 , wherein the step of extracting the immune globulins from the suspension is facilitated using diatomaceous earth at a concentration of about 1% to about 3% weight by volume during filtration.  
     
     
         45 . The method of  claim 38 , wherein the extract containing immune globulins is concentrated through an ultrafiltration membrane.  
     
     
         46 . The method of  claim 38 , wherein the purified extract solution containing immune globulins is concentrated using an ultrafiltration membrane.  
     
     
         47 . The method of  claim 38 , wherein the concentrated purified extract solution containing immune globulins is formulated for final use in one of a liquid and a freeze-dried preparation.

Join the waitlist — get patent alerts

Track US2005080238A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.